Senior Research Fellow, Biopharmaceutical Research and Development, Eli Lilly and Company
Michael R. De Felippis joined Eli Lilly and Company in 1990 after obtaining his doctorate in biochemistry at The Ohio State University. He is currently a Senior Research Fellow in the Biopharmaceutical Research and Development division. His work is focused on commercializing biopharmaceutical...
Read More →
Division Director (Acting), Div. of Inspectional Assessment, OPF, OPQ, CDER, FDA
Acting Director for the Division of Inspection Assessment within OPQ/OPF. His division is primarily responsible for the center level discipline review of facilities and inspections in support of drug applications. He joined the Agency in November 2009 after graduating with his PharmD...
Read More →
Vice President and Global Head, Regulatory CMC, Novartis Pharmaceuticals Corporation
Diane Zezza is Vice President and Global Head Regulatory Affairs, CMC at Novartis Pharmaceuticals. Diane has global responsibilities for CMC regulatory strategies/submissions for all development and lifecycle products. Diane has been a speaker at conferences on regulatory topics including...
Read More →